跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IRINOTECAN HYDROCHLORIDE ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML - HSA Drug Approval Details
Approvals
/
HSA
/
IRINOTECAN HYDROCHLORIDE ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML
Approved
THERAPEUTIC
IRINOTECAN HYDROCHLORIDE ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML
SICHUAN HUIYU PHARMACEUTICAL CO., LTD (CHINA)
🇸🇬 Health Sciences Authority
Approval Date
May 29, 2019
Approval ID
c7a0df0cff93dbb2
Company
SICHUAN HUIYU PHARMACEUTICAL CO., LTD (CHINA)
Type
Therapeutic
Approval Details
Approval Id
c7a0df0cff93dbb2
Drug Name
IRINOTECAN HYDROCHLORIDE ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML
Product Name
IRINOTECAN HYDROCHLORIDE ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML
Approval Number
SIN15701P
Approval Date
2019-05-29
Registrant
ADVAGEN PTE. LTD.
Licence Holder
ADVAGEN PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INFUSION, SOLUTION CONCENTRATE
Route Of Administration
INTRAVENOUS
Atc Code
L01XX19
Atc Item Name
xl 01 xx 19
Pharma Manufacturer Name
ADVAGEN PTE. LTD.
Company Detail Path
/organization/advagen-pte-ltd
Active Ingredients
Irinotecan 17.33 mg/ml eqv Irinotecan Hydrochloride
20 mg/ ml
IRINOTECAN 17.33 MG/ML EQV IRINOTECAN HYDROCHLORIDE
20 MG/ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 29, 2019
Approval ID
c7a0df0cff93dbb2
Type
Therapeutic
Back to HSA Approvals
